Agreement of Two OCT Biometers: A Pilot Study
Run by Alcon Research · NCT07782619 · Data updated 2026-11-12
This pilot study tests whether two OCT biometers, UNITY Dx and Anterion, produce comparable eye measurements for adults across several eye-conditions to help guide IOL power decisions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Alcon Research Industry-sponsored |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | August 17, 2026 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07782619 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a single study eye, representing healthy corneas, keratoconus, daily contact lens use, dry eye symptoms, or prior keratorefractive surgery.
✕Probably not a fit
Patients with active ocular infection, fixation problems, or other ocular conditions that could affect measurement accuracy may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot study compares measurements from two OCT biometers, UNITY Dx and Anterion, in a single-visit assessment. It includes adults with normal corneas, keratoconus, prior corneal laser treatment, habitual contact lens wear, or dry eye, and collects data from one eye per participant. Subjects are grouped by condition and undergo imaging with both devices to evaluate agreement and repeatability. The study is sponsored by Alcon Research and conducted at The Eye Institute of Utah in Salt Lake City. Outcomes focus on measurement concordance between devices rather than clinical endpoints.
Why it matters
Potential benefit: If the biometers agree closely, clinicians may have greater confidence in using either device for preoperative IOL calculations.
How similar studies have gone: Previous studies in imaging devices often show varying levels of agreement; this pilot addresses direct comparison between two biometers in specific eye conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have healthy, clear corneas for the normal cohort; * Have documented keratoconus for the keratoconus cohort; * Have reported use of daily contact lens use for the contact lens cohort; * Have documented dry eye, consisting of signs and symptoms for the dry eye cohort; * Has had previous keratorefractive surgery for the post-refractive surgery cohort; * Able to comprehend and sign the informed consent form. Exclusion Criteria: * Active ocular infection or inflammation; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.
Where it's running
-
The Eye Institute of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Alcon Call Center
- Email: alcon.medinfo@alcon.com
- Phone: 1-888-451-3937
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
China Axial Length Reference
This project will measure axial length in 30,000 Chinese children aged 3 to 18 over three years to create age-specific reference ranges.
-
Unity DX Cornea Study
This study tests a new biometer to see how well it measures corneal and epithelial thickness compared with existing devices in adults with normal, abnormal, or post-surgery eyes.
-
Comparison of a new trifocal IOL with PanOptix Pro IOL in cataract surgery
This study tests whether the investigational trifocal IOL LPYWT0 works as well as the PanOptix Pro trifocal IOL in people with cataracts undergoing cataract surgery in both eyes.
-
Eye drop to reduce redness in adults with irritated eyes
This trial tests if an eye drop containing apraclonidine 0.125% can quickly reduce redness in adults with minor eye irritation compared with a placebo.
-
Eye drop for redness in adults: relief with a new ophthalmic solution
This study tests whether a new eye drop can reduce redness in adults with minor eye irritation or irritation-related redness.
-
Clareon TruPlus IOLs in Bilateral Cataract Surgery
This study tests Clareon TruPlus Monofocal IOLs to see how safe they are and how well they perform for people with both eyes affected by cataracts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.